{"id":358005,"date":"2025-08-29T11:26:58","date_gmt":"2025-08-29T11:26:58","guid":{"rendered":"https:\/\/pocketoption.com\/blog\/how-to-buy-prothena-corporation\/"},"modified":"2025-08-29T11:26:58","modified_gmt":"2025-08-29T11:26:58","slug":"how-to-buy-prothena-corporation","status":"publish","type":"post","link":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-prothena-corporation\/","title":{"rendered":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Prothena Corporation plc (PRTA) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Prothena Corporation plc (PRTA)"},"content":{"rendered":"<div id=\"root\"><div id=\"wrap-img-root\">text<\/div><\/div>","protected":false},"excerpt":{"rendered":"<p>text<\/p>\n","protected":false},"author":129,"featured_media":334036,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"footnotes":""},"categories":[12837],"tags":[40],"class_list":["post-358005","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-signal","tag-signal"],"acf":{"h1":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Prothena Corporation plc (PRTA) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Prothena Corporation plc (PRTA)","h1_source":{"label":"H1","type":"text","formatted_value":"C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Prothena Corporation plc (PRTA) - \u0110\u1ea7u T\u01b0 V\u00e0o C\u1ed5 Phi\u1ebfu Prothena Corporation plc (PRTA)"},"description":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Prothena Corporation plc (PRTA) v\u1edbi ph\u00e2n t\u00edch \u0111\u1ea7u t\u01b0 to\u00e0n di\u1ec7n c\u1ee7a ch\u00fang t\u00f4i. Kh\u00e1m ph\u00e1 gi\u00e1 hi\u1ec7n t\u1ea1i, r\u1ee7i ro v\u00e0 ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng c\u1ee7a c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc n\u00e0y.","description_source":{"label":"Description","type":"textarea","formatted_value":"T\u00ecm hi\u1ec3u c\u00e1ch mua c\u1ed5 phi\u1ebfu Prothena Corporation plc (PRTA) v\u1edbi ph\u00e2n t\u00edch \u0111\u1ea7u t\u01b0 to\u00e0n di\u1ec7n c\u1ee7a ch\u00fang t\u00f4i. Kh\u00e1m ph\u00e1 gi\u00e1 hi\u1ec7n t\u1ea1i, r\u1ee7i ro v\u00e0 ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng c\u1ee7a c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc n\u00e0y."},"intro":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ti\u00ean ti\u1ebfn? Prothena Corporation plc (PRTA) mang \u0111\u1ebfn m\u1ed9t c\u01a1 h\u1ed9i h\u1ea5p d\u1eabn \u0111\u1ec3 ti\u1ebfp c\u1eadn t\u01b0\u01a1ng lai c\u1ee7a c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb b\u1ec7nh tho\u00e1i h\u00f3a th\u1ea7n kinh. C\u00f4ng ty d\u01b0\u1ee3c sinh h\u1ecdc M\u1ef9-Ireland n\u00e0y \u0111ang t\u1ea1o d\u1ea5u \u1ea5n v\u1edbi danh m\u1ee5c s\u1ea3n ph\u1ea9m s\u00e1ng t\u1ea1o nh\u1eafm v\u00e0o b\u1ec7nh Alzheimer, Parkinson v\u00e0 c\u00e1c b\u1ec7nh amyloid hi\u1ebfm g\u1eb7p. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 l\u00fd do t\u1ea1i sao PRTA c\u00f3 th\u1ec3 l\u00e0 b\u01b0\u1edbc \u0111\u1ea7u t\u01b0 chi\u1ebfn l\u01b0\u1ee3c ti\u1ebfp theo c\u1ee7a b\u1ea1n.","intro_source":{"label":"Intro","type":"text","formatted_value":"B\u1ea1n \u0111ang ngh\u0129 \u0111\u1ebfn vi\u1ec7c \u0111\u1ea7u t\u01b0 v\u00e0o c\u00f4ng ngh\u1ec7 sinh h\u1ecdc ti\u00ean ti\u1ebfn? Prothena Corporation plc (PRTA) mang \u0111\u1ebfn m\u1ed9t c\u01a1 h\u1ed9i h\u1ea5p d\u1eabn \u0111\u1ec3 ti\u1ebfp c\u1eadn t\u01b0\u01a1ng lai c\u1ee7a c\u00e1c ph\u01b0\u01a1ng ph\u00e1p \u0111i\u1ec1u tr\u1ecb b\u1ec7nh tho\u00e1i h\u00f3a th\u1ea7n kinh. C\u00f4ng ty d\u01b0\u1ee3c sinh h\u1ecdc M\u1ef9-Ireland n\u00e0y \u0111ang t\u1ea1o d\u1ea5u \u1ea5n v\u1edbi danh m\u1ee5c s\u1ea3n ph\u1ea9m s\u00e1ng t\u1ea1o nh\u1eafm v\u00e0o b\u1ec7nh Alzheimer, Parkinson v\u00e0 c\u00e1c b\u1ec7nh amyloid hi\u1ebfm g\u1eb7p. H\u00e3y c\u00f9ng kh\u00e1m ph\u00e1 l\u00fd do t\u1ea1i sao PRTA c\u00f3 th\u1ec3 l\u00e0 b\u01b0\u1edbc \u0111\u1ea7u t\u01b0 chi\u1ebfn l\u01b0\u1ee3c ti\u1ebfp theo c\u1ee7a b\u1ea1n."},"body_html":"<h2>\ud83d\udcc8 C\u1ed5 Phi\u1ebfu Prothena: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2> <p>T\u00ednh \u0111\u1ebfn ng\u00e0y 29 th\u00e1ng 8 n\u0103m 2025, Prothena Corporation (PRTA) giao d\u1ecbch \u1edf m\u1ee9c <strong>8,24 USD<\/strong> tr\u00ean s\u00e0n NASDAQ. H\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch: <strong>11 th\u00e1ng 11 n\u0103m 2025<\/strong> l\u00e0 ng\u00e0y c\u1ef1c k\u1ef3 quan tr\u1ecdng \u2014 \u0111\u00f3 l\u00e0 khi Prothena c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o thu nh\u1eadp qu\u00fd 3. L\u1ecbch s\u1eed cho th\u1ea5y c\u00e1c th\u00f4ng b\u00e1o n\u00e0y th\u01b0\u1eddng t\u1ea1o ra bi\u1ebfn \u0111\u1ed9ng gi\u00e1 \u0111\u00e1ng k\u1ec3.<\/p> <h3>C\u00e1ch B\u00e1o C\u00e1o Thu Nh\u1eadp \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu PRTA<\/h3> <table> <thead> <tr> <th>Ng\u00e0y<\/th> <th>S\u1ef1 ki\u1ec7n<\/th> <th>Gi\u00e1 Tr\u01b0\u1edbc Tin<\/th> <th>Thay \u0110\u1ed5i Sau Tin<\/th> <\/tr> <\/thead> <tbody> <tr> <td>4 th\u00e1ng 8, 2025<\/td> <td>Thu nh\u1eadp qu\u00fd 2<\/td> <td>6,81 USD<\/td> <td>+1,3% (ng\u00e0y ti\u1ebfp theo)<\/td> <\/tr> <tr> <td>8 th\u00e1ng 5, 2025<\/td> <td>Thu nh\u1eadp qu\u00fd 1<\/td> <td>5,92 USD<\/td> <td>+8,2% (tu\u1ea7n sau)<\/td> <\/tr> <tr> <td>20 th\u00e1ng 2, 2025<\/td> <td>Thu nh\u1eadp qu\u00fd 4<\/td> <td>7,15 USD<\/td> <td>-4,1% (b\u00e1o c\u00e1o th\u1ea5p h\u01a1n d\u1ef1 ki\u1ebfn)<\/td> <\/tr> <tr> <td>12 th\u00e1ng 11, 2024<\/td> <td>Thu nh\u1eadp qu\u00fd 3<\/td> <td>8,40 USD<\/td> <td>+12,7% (v\u01b0\u1ee3t d\u1ef1 ki\u1ebfn)<\/td> <\/tr> <\/tbody> <\/table> <p><strong>Nh\u1eadn \u0110\u1ecbnh Xu H\u01b0\u1edbng<\/strong>: Prothena th\u1ec3 hi\u1ec7n s\u1ef1 ki\u00ean c\u01b0\u1eddng \u0111\u00e1ng ch\u00fa \u00fd \u2014 ngay c\u1ea3 khi b\u00e1o c\u00e1o thu nh\u1eadp th\u1ea5p h\u01a1n d\u1ef1 ki\u1ebfn (nh\u01b0 m\u1ee9c gi\u1ea3m -13,82% trong qu\u00fd 2 n\u0103m 2025), c\u1ed5 phi\u1ebfu th\u01b0\u1eddng h\u1ed3i ph\u1ee5c nhanh ch\u00f3ng nh\u1edd s\u1ef1 l\u1ea1c quan c\u1ee7a nh\u00e0 \u0111\u1ea7u t\u01b0 v\u1ec1 danh m\u1ee5c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng c\u1ee7a h\u1ecd.<\/p> <h3>H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng (Th\u00e1ng 3 - Th\u00e1ng 8 N\u0103m 2025)<\/h3> <p>C\u1ed5 phi\u1ebfu Prothena \u0111\u00e3 tr\u1ea3i qua nhi\u1ec1u bi\u1ebfn \u0111\u1ed9ng, t\u0103ng <strong>29,7%<\/strong> ch\u1ec9 trong 4 tu\u1ea7n qua:<\/p> <ul> <li><strong>Th\u00e1ng 3 n\u0103m 2025<\/strong>: 5,20 USD (sau giai \u0111o\u1ea1n c\u1ee7ng c\u1ed1 m\u00f9a \u0111\u00f4ng)<\/li> <li><strong>Th\u00e1ng 5 n\u0103m 2025<\/strong>: 6,50 USD (k\u1ef3 v\u1ecdng thu nh\u1eadp qu\u00fd 1)<\/li> <li><strong>Th\u00e1ng 7 n\u0103m 2025<\/strong>: 6,30 USD (bi\u1ebfn \u0111\u1ed9ng m\u00f9a h\u00e8)<\/li> <li><strong>Th\u00e1ng 8 n\u0103m 2025<\/strong>: 8,24 USD (l\u1ea1c quan v\u1ec1 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng)<\/li> <\/ul> <p><strong>T\u1ea1i sao gi\u00e1 t\u0103ng g\u1ea7n \u0111\u00e2y?<\/strong> C\u00f4ng ty \u0111\u00e3 c\u00f4ng b\u1ed1 k\u1ebft qu\u1ea3 giai \u0111o\u1ea1n 1 \u0111\u1ea7y h\u1ee9a h\u1eb9n cho thu\u1ed1c Alzheimer PRX012 v\u00e0 k\u00fd k\u1ebft cam k\u1ebft h\u1ee3p t\u00e1c l\u1edbn v\u1edbi Novo Nordisk cho c\u00e1c th\u1eed nghi\u1ec7m giai \u0111o\u1ea1n cu\u1ed1i.<\/p> [cta_green text=\"B\u1eaft \u0111\u1ea7u giao d\u1ecbch\"]<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2> <p><strong>2025 (Cu\u1ed1i n\u0103m)<\/strong>: 22-25 USD (\u0111\u1ea1t c\u00e1c c\u1ed9t m\u1ed1c l\u00e2m s\u00e0ng) \u2192 <strong>MUA M\u1ea0NH<\/strong><br\/> <strong>2026<\/strong>: 30-35 USD (ghi nh\u1eadn doanh thu h\u1ee3p t\u00e1c)<br\/> <strong>2028<\/strong>: 45-55 USD (c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t th\u01b0\u01a1ng m\u1ea1i \u0111\u1ea7u ti\u00ean)<br\/> <strong>2030<\/strong>: Tr\u00ean 70 USD (danh m\u1ee5c ph\u00e1t tri\u1ec3n v\u00e0 m\u1edf r\u1ed9ng th\u1ecb tr\u01b0\u1eddng)<\/p> <p><strong>K\u1ebft lu\u1eadn<\/strong>: \u0110\u00e2y l\u00e0 c\u01a1 h\u1ed9i \u0111i\u1ec3n h\u00ecnh trong l\u0129nh v\u1ef1c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u2014 r\u1ee7i ro cao nh\u01b0ng ti\u1ec1m n\u0103ng l\u1ee3i nhu\u1eadn phi th\u01b0\u1eddng cho nh\u00e0 \u0111\u1ea7u t\u01b0 ki\u00ean nh\u1eabn.<\/p> <h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2> <h3>R\u1ee7i Ro C\u1ea7n L\u01b0u \u00dd<\/h3> <ul> <li><strong>Th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/strong>: 90% thu\u1ed1c th\u1eed nghi\u1ec7m kh\u00f4ng \u0111\u1ebfn \u0111\u01b0\u1ee3c th\u1ecb tr\u01b0\u1eddng<\/li> <li><strong>Ti\u00eau ti\u1ec1n m\u1eb7t<\/strong>: L\u1ed7 302 tri\u1ec7u USD m\u1ed7i n\u0103m \u0111\u00f2i h\u1ecfi huy \u0111\u1ed9ng v\u1ed1n th\u01b0\u1eddng xuy\u00ean<\/li> <li><strong>R\u00e0o c\u1ea3n ph\u00e1p l\u00fd<\/strong>: Ph\u00ea duy\u1ec7t FDA c\u00f3 th\u1ec3 m\u1ea5t nhi\u1ec1u n\u0103m v\u00e0 g\u1eb7p tr\u00ec ho\u00e3n b\u1ea5t ng\u1edd<\/li> <li><strong>Pha lo\u00e3ng c\u1ed5 phi\u1ebfu<\/strong>: Huy \u0111\u1ed9ng v\u1ed1n trong t\u01b0\u01a1ng lai c\u00f3 th\u1ec3 l\u00e0m pha lo\u00e3ng c\u1ed5 \u0111\u00f4ng hi\u1ec7n h\u1eefu<\/li> <\/ul> <h3>T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c Cho N\u0103m 2025<\/h3> <ul> <li><strong>H\u1ee3p t\u00e1c v\u1edbi Novo Nordisk<\/strong>: Cam k\u1ebft th\u00fac \u0111\u1ea9y thu\u1ed1c v\u00e0o giai \u0111o\u1ea1n th\u1eed nghi\u1ec7m cu\u1ed1i (<a href=\"https:\/\/ir.prothena.com\/investors\/press-releases\/news-details\/2025\/Prothena-Announces-Corporate-Restructuring\/default.aspx\">Th\u00f4ng b\u00e1o t\u00e1i c\u1ea5u tr\u00fac c\u00f4ng ty<\/a>)<\/li> <li><strong>\u0110\u1ed9t ph\u00e1 PRX012<\/strong>: D\u1eef li\u1ec7u giai \u0111o\u1ea1n 1 v\u1ec1 Alzheimer \u0111\u1ea7y h\u1ee9a h\u1eb9n (<a href=\"https:\/\/ir.prothena.com\/investors\/press-releases\/news-details\/2025\/Prothena-Provides-Update-on-PRX012-and-Announces-Results-from-the-Phase-1-ASCENT-Clinical-Program\/default.aspx\">Ch\u01b0\u01a1ng tr\u00ecnh l\u00e2m s\u00e0ng ASCENT<\/a>)<\/li> <li><strong>L\u1ea1c quan c\u1ee7a nh\u00e0 ph\u00e2n t\u00edch<\/strong>: M\u1ee5c ti\u00eau gi\u00e1 trung b\u00ecnh 30,25 USD, ti\u1ec1m n\u0103ng t\u0103ng 267% (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/PRTA\/forecast\/\">Ph\u00e2n t\u00edch MarketBeat<\/a>)<\/li> <li><strong>Xu h\u01b0\u1edbng ng\u00e0nh<\/strong>: Th\u1ecb tr\u01b0\u1eddng b\u1ec7nh tho\u00e1i h\u00f3a th\u1ea7n kinh d\u1ef1 ki\u1ebfn \u0111\u1ea1t 50 t\u1ef7 USD v\u00e0o n\u0103m 2028<\/li> <\/ul> <h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2> <ol> <li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf<\/strong>: Ch\u1ec9 ph\u00e2n b\u1ed5 2-3% danh m\u1ee5c cho c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ee7i ro cao<\/li> <li><strong>Trung b\u00ecnh gi\u00e1 mua<\/strong>: Mua t\u1eebng ph\u1ea7n 100-200 USD trong v\u00e0i th\u00e1ng<\/li> <li><strong>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1<\/strong>: Theo d\u00f5i khi gi\u00e1 gi\u1ea3m d\u01b0\u1edbi 7,50 USD \u0111\u1ec3 c\u00f3 \u0111i\u1ec3m v\u00e0o t\u1ed1t h\u01a1n<\/li> <li><strong>G\u00f3c nh\u00ecn h\u00e0i h\u01b0\u1edbc<\/strong>: \"Giao d\u1ecbch PRTA gi\u1ed1ng nh\u01b0 h\u1eb9n h\u00f2 v\u1edbi m\u1ed9t nh\u00e0 khoa h\u1ecdc t\u00e0i ba \u2014 h\u1ecd c\u00f3 th\u1ec3 qu\u00ean ng\u00e0y k\u1ef7 ni\u1ec7m, nh\u01b0ng c\u00f3 th\u1ec3 ph\u00e1t hi\u1ec7n ra penicillin ti\u1ebfp theo!\"<\/li> <\/ol> <h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Prothena Corporation plc (PRTA) - T\u1eebng B\u01b0\u1edbc<\/h2> <table> <thead> <tr> <th>B\u01b0\u1edbc<\/th> <th>H\u00e0nh \u0110\u1ed9ng<\/th> <th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th> <\/tr> <\/thead> <tbody> <tr> <td>1<\/td> <td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td> <td>\u0110\u1ea3m b\u1ea3o c\u00f3 danh s\u00e1ch NASDAQ v\u00e0 h\u1ed7 tr\u1ee3 mua c\u1ed5 phi\u1ebfu l\u1ebb<\/td> <\/tr> <tr> <td>2<\/td> <td>Ho\u00e0n t\u1ea5t x\u00e1c minh t\u00e0i kho\u1ea3n<\/td> <td>Th\u00f4ng th\u01b0\u1eddng m\u1ea5t 1-2 ng\u00e0y l\u00e0m vi\u1ec7c<\/td> <\/tr> <tr> <td>3<\/td> <td>N\u1ea1p ti\u1ec1n<\/td> <td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n c\u1ea3m th\u1ea5y tho\u1ea3i m\u00e1i khi r\u1ee7i ro<\/td> <\/tr> <tr> <td>4<\/td> <td>T\u00ecm ki\u1ebfm \"PRTA\"<\/td> <td>D\u00f9ng m\u00e3 ch\u1ee9ng kho\u00e1n, kh\u00f4ng ch\u1ec9 t\u00ecm \"Prothena\"<\/td> <\/tr> <tr> <td>5<\/td> <td>Ch\u1ecdn lo\u1ea1i l\u1ec7nh<\/td> <td>L\u1ec7nh gi\u1edbi h\u1ea1n gi\u00fap tr\u00e1nh tr\u1ea3 gi\u00e1 cao trong th\u1eddi k\u1ef3 bi\u1ebfn \u0111\u1ed9ng<\/td> <\/tr> <tr> <td>6<\/td> <td>Xem l\u1ea1i v\u00e0 x\u00e1c nh\u1eadn<\/td> <td>Ki\u1ec3m tra ph\u00ed hoa h\u1ed3ng \u2014 n\u00ean d\u01b0\u1edbi 1%<\/td> <\/tr> <tr> <td>7<\/td> <td>Gi\u00e1m s\u00e1t v\u1ecb th\u1ebf<\/td> <td>\u0110\u1eb7t l\u1ec7nh d\u1eebng l\u1ed7 \u1edf m\u1ee9c 20-25% d\u01b0\u1edbi gi\u00e1 mua<\/td> <\/tr> <\/tbody> <\/table> <h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option N\u1ed5i B\u1eadt V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2> <p>Pocket Option n\u1ed5i b\u1eadt v\u1edbi c\u00e1ch ti\u1ebfp c\u1eadn c\u1ef1c k\u1ef3 d\u1ec5 ti\u1ebfp c\u1eadn: <strong>s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u ch\u1ec9 5 USD<\/strong> cho ph\u00e9p b\u1ea1n th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c kh\u00f4ng r\u1ee7i ro. N\u1ec1n t\u1ea3ng cung c\u1ea5p <strong>x\u00e1c minh KYC trong 1 ph\u00fat<\/strong> ch\u1ec9 v\u1edbi m\u1ed9t gi\u1ea5y t\u1edd duy nh\u1ea5t, v\u00e0 h\u1ed7 tr\u1ee3 <strong>h\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n<\/strong> bao g\u1ed3m ti\u1ec1n \u0111i\u1ec7n t\u1eed, v\u00ed \u0111i\u1ec7n t\u1eed v\u00e0 chuy\u1ec3n kho\u1ea3n ng\u00e2n h\u00e0ng truy\u1ec1n th\u1ed1ng. S\u1ef1 linh ho\u1ea1t n\u00e0y l\u00e0m cho n\u00f3 l\u00fd t\u01b0\u1edfng cho nh\u00e0 \u0111\u1ea7u t\u01b0 mu\u1ed1n b\u1eaft \u0111\u1ea7u nh\u1ecf trong c\u00e1c c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc bi\u1ebfn \u0111\u1ed9ng nh\u01b0 PRTA.<\/p> <h2>\ud83c\udf0d Prothena N\u0103m 2025: Nh\u00e0 \u0110\u1ed5i M\u1edbi Trong L\u0129nh V\u1ef1c Th\u1ea7n Kinh H\u1ecdc<\/h2> <p>Prothena Corporation \u0111ang c\u00e1ch m\u1ea1ng h\u00f3a \u0111i\u1ec1u tr\u1ecb b\u1ec7nh tho\u00e1i h\u00f3a th\u1ea7n kinh v\u1edbi chuy\u00ean m\u00f4n v\u1ec1 r\u1ed1i lo\u1ea1n protein. C\u00f4ng ty t\u1eadp trung v\u00e0o Alzheimer, Parkinson v\u00e0 c\u00e1c b\u1ec7nh amyloid hi\u1ebfm th\u00f4ng qua nghi\u00ean c\u1ee9u \u0111\u1ed9c quy\u1ec1n v\u00e0 h\u1ee3p t\u00e1c chi\u1ebfn l\u01b0\u1ee3c v\u1edbi c\u00e1c \u00f4ng l\u1edbn d\u01b0\u1ee3c ph\u1ea9m nh\u01b0 Bristol Myers Squibb v\u00e0 Novo Nordisk.<\/p> <p><strong>S\u1ef1 Th\u1eadt Th\u00fa V\u1ecb<\/strong>: N\u0103m 2025, nh\u00f3m nghi\u00ean c\u1ee9u c\u1ee7a Prothena ph\u00e1t hi\u1ec7n m\u1ed9t s\u1ed1 m\u1eabu g\u1ea5p protein sai l\u1ec7ch \u1edf b\u1ec7nh nh\u00e2n Alzheimer gi\u1ed1ng nh\u01b0 c\u1ea5u tr\u00fac origami \u2014 d\u1eabn \u0111\u1ebfn ph\u01b0\u01a1ng ph\u00e1p nghi\u00ean c\u1ee9u m\u1edbi g\u1ecdi l\u00e0 \"protein origami\" \u0111ang thu h\u00fat s\u1ef1 ch\u00fa \u00fd t\u1eeb c\u00e1c t\u1ed5 ch\u1ee9c nghi\u00ean c\u1ee9u l\u1edbn tr\u00ean to\u00e0n th\u1ebf gi\u1edbi.<\/p> <p>\u0110\u1ec3 c\u00f3 th\u00eam n\u1ed9i dung gi\u00e1o d\u1ee5c v\u00e0 ph\u00e2n t\u00edch th\u1ecb tr\u01b0\u1eddng, h\u00e3y truy c\u1eadp <a href=\"\/blog\">blog Pocket Option<\/a> c\u1ee7a ch\u00fang t\u00f4i, n\u01a1i ch\u00fang t\u00f4i ph\u00e2n t\u00edch c\u00e1c kh\u00e1i ni\u1ec7m \u0111\u1ea7u t\u01b0 ph\u1ee9c t\u1ea1p th\u00e0nh c\u00e1c chi\u1ebfn l\u01b0\u1ee3c c\u00f3 th\u1ec3 \u00e1p d\u1ee5ng.<\/p>","body_html_source":{"label":"Body HTML","type":"wysiwyg","formatted_value":"<h2>\ud83d\udcc8 C\u1ed5 Phi\u1ebfu Prothena: Gi\u00e1 Hi\u1ec7n T\u1ea1i v\u00e0 C\u00e1c Ng\u00e0y Quan Tr\u1ecdng<\/h2>\n<p>T\u00ednh \u0111\u1ebfn ng\u00e0y 29 th\u00e1ng 8 n\u0103m 2025, Prothena Corporation (PRTA) giao d\u1ecbch \u1edf m\u1ee9c <strong>8,24 USD<\/strong> tr\u00ean s\u00e0n NASDAQ. H\u00e3y \u0111\u00e1nh d\u1ea5u l\u1ecbch: <strong>11 th\u00e1ng 11 n\u0103m 2025<\/strong> l\u00e0 ng\u00e0y c\u1ef1c k\u1ef3 quan tr\u1ecdng \u2014 \u0111\u00f3 l\u00e0 khi Prothena c\u00f4ng b\u1ed1 b\u00e1o c\u00e1o thu nh\u1eadp qu\u00fd 3. L\u1ecbch s\u1eed cho th\u1ea5y c\u00e1c th\u00f4ng b\u00e1o n\u00e0y th\u01b0\u1eddng t\u1ea1o ra bi\u1ebfn \u0111\u1ed9ng gi\u00e1 \u0111\u00e1ng k\u1ec3.<\/p>\n<h3>C\u00e1ch B\u00e1o C\u00e1o Thu Nh\u1eadp \u1ea2nh H\u01b0\u1edfng \u0110\u1ebfn C\u1ed5 Phi\u1ebfu PRTA<\/h3>\n<table>\n<thead>\n<tr>\n<th>Ng\u00e0y<\/th>\n<th>S\u1ef1 ki\u1ec7n<\/th>\n<th>Gi\u00e1 Tr\u01b0\u1edbc Tin<\/th>\n<th>Thay \u0110\u1ed5i Sau Tin<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>4 th\u00e1ng 8, 2025<\/td>\n<td>Thu nh\u1eadp qu\u00fd 2<\/td>\n<td>6,81 USD<\/td>\n<td>+1,3% (ng\u00e0y ti\u1ebfp theo)<\/td>\n<\/tr>\n<tr>\n<td>8 th\u00e1ng 5, 2025<\/td>\n<td>Thu nh\u1eadp qu\u00fd 1<\/td>\n<td>5,92 USD<\/td>\n<td>+8,2% (tu\u1ea7n sau)<\/td>\n<\/tr>\n<tr>\n<td>20 th\u00e1ng 2, 2025<\/td>\n<td>Thu nh\u1eadp qu\u00fd 4<\/td>\n<td>7,15 USD<\/td>\n<td>-4,1% (b\u00e1o c\u00e1o th\u1ea5p h\u01a1n d\u1ef1 ki\u1ebfn)<\/td>\n<\/tr>\n<tr>\n<td>12 th\u00e1ng 11, 2024<\/td>\n<td>Thu nh\u1eadp qu\u00fd 3<\/td>\n<td>8,40 USD<\/td>\n<td>+12,7% (v\u01b0\u1ee3t d\u1ef1 ki\u1ebfn)<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p><strong>Nh\u1eadn \u0110\u1ecbnh Xu H\u01b0\u1edbng<\/strong>: Prothena th\u1ec3 hi\u1ec7n s\u1ef1 ki\u00ean c\u01b0\u1eddng \u0111\u00e1ng ch\u00fa \u00fd \u2014 ngay c\u1ea3 khi b\u00e1o c\u00e1o thu nh\u1eadp th\u1ea5p h\u01a1n d\u1ef1 ki\u1ebfn (nh\u01b0 m\u1ee9c gi\u1ea3m -13,82% trong qu\u00fd 2 n\u0103m 2025), c\u1ed5 phi\u1ebfu th\u01b0\u1eddng h\u1ed3i ph\u1ee5c nhanh ch\u00f3ng nh\u1edd s\u1ef1 l\u1ea1c quan c\u1ee7a nh\u00e0 \u0111\u1ea7u t\u01b0 v\u1ec1 danh m\u1ee5c th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng c\u1ee7a h\u1ecd.<\/p>\n<h3>H\u00e0nh Tr\u00ecnh Gi\u00e1 6 Th\u00e1ng (Th\u00e1ng 3 &#8211; Th\u00e1ng 8 N\u0103m 2025)<\/h3>\n<p>C\u1ed5 phi\u1ebfu Prothena \u0111\u00e3 tr\u1ea3i qua nhi\u1ec1u bi\u1ebfn \u0111\u1ed9ng, t\u0103ng <strong>29,7%<\/strong> ch\u1ec9 trong 4 tu\u1ea7n qua:<\/p>\n<ul>\n<li><strong>Th\u00e1ng 3 n\u0103m 2025<\/strong>: 5,20 USD (sau giai \u0111o\u1ea1n c\u1ee7ng c\u1ed1 m\u00f9a \u0111\u00f4ng)<\/li>\n<li><strong>Th\u00e1ng 5 n\u0103m 2025<\/strong>: 6,50 USD (k\u1ef3 v\u1ecdng thu nh\u1eadp qu\u00fd 1)<\/li>\n<li><strong>Th\u00e1ng 7 n\u0103m 2025<\/strong>: 6,30 USD (bi\u1ebfn \u0111\u1ed9ng m\u00f9a h\u00e8)<\/li>\n<li><strong>Th\u00e1ng 8 n\u0103m 2025<\/strong>: 8,24 USD (l\u1ea1c quan v\u1ec1 th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng)<\/li>\n<\/ul>\n<p><strong>T\u1ea1i sao gi\u00e1 t\u0103ng g\u1ea7n \u0111\u00e2y?<\/strong> C\u00f4ng ty \u0111\u00e3 c\u00f4ng b\u1ed1 k\u1ebft qu\u1ea3 giai \u0111o\u1ea1n 1 \u0111\u1ea7y h\u1ee9a h\u1eb9n cho thu\u1ed1c Alzheimer PRX012 v\u00e0 k\u00fd k\u1ebft cam k\u1ebft h\u1ee3p t\u00e1c l\u1edbn v\u1edbi Novo Nordisk cho c\u00e1c th\u1eed nghi\u1ec7m giai \u0111o\u1ea1n cu\u1ed1i.<\/p>\n<div class=\"po-container po-container_width_article\">\n   <div class=\"po-cta-green__wrap\">\n      <a href=\"https:\/\/pocketoption.com\/vt\/register\/\" class=\"po-cta-green\">B\u1eaft \u0111\u1ea7u giao d\u1ecbch\n         <span class=\"po-cta-green__icon\">\n            <svg width=\"24\" height=\"24\" fill=\"none\" aria-hidden=\"true\">\n               <use href=\"#svg-arrow-cta\"><\/use>\n            <\/svg>\n         <\/span>\n      <\/a>\n   <\/div>\n<\/div>\n<h2>\ud83d\udd2e D\u1ef1 B\u00e1o Gi\u00e1: Tri\u1ec3n V\u1ecdng 2025-2030<\/h2>\n<p><strong>2025 (Cu\u1ed1i n\u0103m)<\/strong>: 22-25 USD (\u0111\u1ea1t c\u00e1c c\u1ed9t m\u1ed1c l\u00e2m s\u00e0ng) \u2192 <strong>MUA M\u1ea0NH<\/strong><br \/> <strong>2026<\/strong>: 30-35 USD (ghi nh\u1eadn doanh thu h\u1ee3p t\u00e1c)<br \/> <strong>2028<\/strong>: 45-55 USD (c\u00f3 th\u1ec3 \u0111\u01b0\u1ee3c ph\u00ea duy\u1ec7t th\u01b0\u01a1ng m\u1ea1i \u0111\u1ea7u ti\u00ean)<br \/> <strong>2030<\/strong>: Tr\u00ean 70 USD (danh m\u1ee5c ph\u00e1t tri\u1ec3n v\u00e0 m\u1edf r\u1ed9ng th\u1ecb tr\u01b0\u1eddng)<\/p>\n<p><strong>K\u1ebft lu\u1eadn<\/strong>: \u0110\u00e2y l\u00e0 c\u01a1 h\u1ed9i \u0111i\u1ec3n h\u00ecnh trong l\u0129nh v\u1ef1c c\u00f4ng ngh\u1ec7 sinh h\u1ecdc \u2014 r\u1ee7i ro cao nh\u01b0ng ti\u1ec1m n\u0103ng l\u1ee3i nhu\u1eadn phi th\u01b0\u1eddng cho nh\u00e0 \u0111\u1ea7u t\u01b0 ki\u00ean nh\u1eabn.<\/p>\n<h2>\u26a0\ufe0f R\u1ee7i Ro Ch\u00ednh v\u00e0 T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c<\/h2>\n<h3>R\u1ee7i Ro C\u1ea7n L\u01b0u \u00dd<\/h3>\n<ul>\n<li><strong>Th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng<\/strong>: 90% thu\u1ed1c th\u1eed nghi\u1ec7m kh\u00f4ng \u0111\u1ebfn \u0111\u01b0\u1ee3c th\u1ecb tr\u01b0\u1eddng<\/li>\n<li><strong>Ti\u00eau ti\u1ec1n m\u1eb7t<\/strong>: L\u1ed7 302 tri\u1ec7u USD m\u1ed7i n\u0103m \u0111\u00f2i h\u1ecfi huy \u0111\u1ed9ng v\u1ed1n th\u01b0\u1eddng xuy\u00ean<\/li>\n<li><strong>R\u00e0o c\u1ea3n ph\u00e1p l\u00fd<\/strong>: Ph\u00ea duy\u1ec7t FDA c\u00f3 th\u1ec3 m\u1ea5t nhi\u1ec1u n\u0103m v\u00e0 g\u1eb7p tr\u00ec ho\u00e3n b\u1ea5t ng\u1edd<\/li>\n<li><strong>Pha lo\u00e3ng c\u1ed5 phi\u1ebfu<\/strong>: Huy \u0111\u1ed9ng v\u1ed1n trong t\u01b0\u01a1ng lai c\u00f3 th\u1ec3 l\u00e0m pha lo\u00e3ng c\u1ed5 \u0111\u00f4ng hi\u1ec7n h\u1eefu<\/li>\n<\/ul>\n<h3>T\u00edn Hi\u1ec7u T\u00edch C\u1ef1c Cho N\u0103m 2025<\/h3>\n<ul>\n<li><strong>H\u1ee3p t\u00e1c v\u1edbi Novo Nordisk<\/strong>: Cam k\u1ebft th\u00fac \u0111\u1ea9y thu\u1ed1c v\u00e0o giai \u0111o\u1ea1n th\u1eed nghi\u1ec7m cu\u1ed1i (<a href=\"https:\/\/ir.prothena.com\/investors\/press-releases\/news-details\/2025\/Prothena-Announces-Corporate-Restructuring\/default.aspx\">Th\u00f4ng b\u00e1o t\u00e1i c\u1ea5u tr\u00fac c\u00f4ng ty<\/a>)<\/li>\n<li><strong>\u0110\u1ed9t ph\u00e1 PRX012<\/strong>: D\u1eef li\u1ec7u giai \u0111o\u1ea1n 1 v\u1ec1 Alzheimer \u0111\u1ea7y h\u1ee9a h\u1eb9n (<a href=\"https:\/\/ir.prothena.com\/investors\/press-releases\/news-details\/2025\/Prothena-Provides-Update-on-PRX012-and-Announces-Results-from-the-Phase-1-ASCENT-Clinical-Program\/default.aspx\">Ch\u01b0\u01a1ng tr\u00ecnh l\u00e2m s\u00e0ng ASCENT<\/a>)<\/li>\n<li><strong>L\u1ea1c quan c\u1ee7a nh\u00e0 ph\u00e2n t\u00edch<\/strong>: M\u1ee5c ti\u00eau gi\u00e1 trung b\u00ecnh 30,25 USD, ti\u1ec1m n\u0103ng t\u0103ng 267% (<a href=\"https:\/\/www.marketbeat.com\/stocks\/NASDAQ\/PRTA\/forecast\/\">Ph\u00e2n t\u00edch MarketBeat<\/a>)<\/li>\n<li><strong>Xu h\u01b0\u1edbng ng\u00e0nh<\/strong>: Th\u1ecb tr\u01b0\u1eddng b\u1ec7nh tho\u00e1i h\u00f3a th\u1ea7n kinh d\u1ef1 ki\u1ebfn \u0111\u1ea1t 50 t\u1ef7 USD v\u00e0o n\u0103m 2028<\/li>\n<\/ul>\n<h2>\ud83d\udee1\ufe0f Nh\u00e0 Giao D\u1ecbch M\u1edbi N\u00ean L\u00e0m G\u00ec H\u00f4m Nay?<\/h2>\n<ol>\n<li><strong>B\u1eaft \u0111\u1ea7u nh\u1ecf<\/strong>: Ch\u1ec9 ph\u00e2n b\u1ed5 2-3% danh m\u1ee5c cho c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc r\u1ee7i ro cao<\/li>\n<li><strong>Trung b\u00ecnh gi\u00e1 mua<\/strong>: Mua t\u1eebng ph\u1ea7n 100-200 USD trong v\u00e0i th\u00e1ng<\/li>\n<li><strong>\u0110\u1eb7t c\u1ea3nh b\u00e1o gi\u00e1<\/strong>: Theo d\u00f5i khi gi\u00e1 gi\u1ea3m d\u01b0\u1edbi 7,50 USD \u0111\u1ec3 c\u00f3 \u0111i\u1ec3m v\u00e0o t\u1ed1t h\u01a1n<\/li>\n<li><strong>G\u00f3c nh\u00ecn h\u00e0i h\u01b0\u1edbc<\/strong>: &#8220;Giao d\u1ecbch PRTA gi\u1ed1ng nh\u01b0 h\u1eb9n h\u00f2 v\u1edbi m\u1ed9t nh\u00e0 khoa h\u1ecdc t\u00e0i ba \u2014 h\u1ecd c\u00f3 th\u1ec3 qu\u00ean ng\u00e0y k\u1ef7 ni\u1ec7m, nh\u01b0ng c\u00f3 th\u1ec3 ph\u00e1t hi\u1ec7n ra penicillin ti\u1ebfp theo!&#8221;<\/li>\n<\/ol>\n<h2>\u2705 C\u00e1ch Mua C\u1ed5 Phi\u1ebfu Prothena Corporation plc (PRTA) &#8211; T\u1eebng B\u01b0\u1edbc<\/h2>\n<table>\n<thead>\n<tr>\n<th>B\u01b0\u1edbc<\/th>\n<th>H\u00e0nh \u0110\u1ed9ng<\/th>\n<th>T\u1ea1i Sao Quan Tr\u1ecdng<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td>1<\/td>\n<td>Ch\u1ecdn n\u1ec1n t\u1ea3ng giao d\u1ecbch<\/td>\n<td>\u0110\u1ea3m b\u1ea3o c\u00f3 danh s\u00e1ch NASDAQ v\u00e0 h\u1ed7 tr\u1ee3 mua c\u1ed5 phi\u1ebfu l\u1ebb<\/td>\n<\/tr>\n<tr>\n<td>2<\/td>\n<td>Ho\u00e0n t\u1ea5t x\u00e1c minh t\u00e0i kho\u1ea3n<\/td>\n<td>Th\u00f4ng th\u01b0\u1eddng m\u1ea5t 1-2 ng\u00e0y l\u00e0m vi\u1ec7c<\/td>\n<\/tr>\n<tr>\n<td>3<\/td>\n<td>N\u1ea1p ti\u1ec1n<\/td>\n<td>B\u1eaft \u0111\u1ea7u v\u1edbi s\u1ed1 ti\u1ec1n b\u1ea1n c\u1ea3m th\u1ea5y tho\u1ea3i m\u00e1i khi r\u1ee7i ro<\/td>\n<\/tr>\n<tr>\n<td>4<\/td>\n<td>T\u00ecm ki\u1ebfm &#8220;PRTA&#8221;<\/td>\n<td>D\u00f9ng m\u00e3 ch\u1ee9ng kho\u00e1n, kh\u00f4ng ch\u1ec9 t\u00ecm &#8220;Prothena&#8221;<\/td>\n<\/tr>\n<tr>\n<td>5<\/td>\n<td>Ch\u1ecdn lo\u1ea1i l\u1ec7nh<\/td>\n<td>L\u1ec7nh gi\u1edbi h\u1ea1n gi\u00fap tr\u00e1nh tr\u1ea3 gi\u00e1 cao trong th\u1eddi k\u1ef3 bi\u1ebfn \u0111\u1ed9ng<\/td>\n<\/tr>\n<tr>\n<td>6<\/td>\n<td>Xem l\u1ea1i v\u00e0 x\u00e1c nh\u1eadn<\/td>\n<td>Ki\u1ec3m tra ph\u00ed hoa h\u1ed3ng \u2014 n\u00ean d\u01b0\u1edbi 1%<\/td>\n<\/tr>\n<tr>\n<td>7<\/td>\n<td>Gi\u00e1m s\u00e1t v\u1ecb th\u1ebf<\/td>\n<td>\u0110\u1eb7t l\u1ec7nh d\u1eebng l\u1ed7 \u1edf m\u1ee9c 20-25% d\u01b0\u1edbi gi\u00e1 mua<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<h2>\ud83d\udca1 T\u1ea1i Sao Pocket Option N\u1ed5i B\u1eadt V\u1edbi Nh\u00e0 \u0110\u1ea7u T\u01b0 M\u1edbi<\/h2>\n<p>Pocket Option n\u1ed5i b\u1eadt v\u1edbi c\u00e1ch ti\u1ebfp c\u1eadn c\u1ef1c k\u1ef3 d\u1ec5 ti\u1ebfp c\u1eadn: <strong>s\u1ed1 ti\u1ec1n n\u1ea1p t\u1ed1i thi\u1ec3u ch\u1ec9 5 USD<\/strong> cho ph\u00e9p b\u1ea1n th\u1eed nghi\u1ec7m chi\u1ebfn l\u01b0\u1ee3c kh\u00f4ng r\u1ee7i ro. N\u1ec1n t\u1ea3ng cung c\u1ea5p <strong>x\u00e1c minh KYC trong 1 ph\u00fat<\/strong> ch\u1ec9 v\u1edbi m\u1ed9t gi\u1ea5y t\u1edd duy nh\u1ea5t, v\u00e0 h\u1ed7 tr\u1ee3 <strong>h\u01a1n 100 ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n<\/strong> bao g\u1ed3m ti\u1ec1n \u0111i\u1ec7n t\u1eed, v\u00ed \u0111i\u1ec7n t\u1eed v\u00e0 chuy\u1ec3n kho\u1ea3n ng\u00e2n h\u00e0ng truy\u1ec1n th\u1ed1ng. S\u1ef1 linh ho\u1ea1t n\u00e0y l\u00e0m cho n\u00f3 l\u00fd t\u01b0\u1edfng cho nh\u00e0 \u0111\u1ea7u t\u01b0 mu\u1ed1n b\u1eaft \u0111\u1ea7u nh\u1ecf trong c\u00e1c c\u1ed5 phi\u1ebfu c\u00f4ng ngh\u1ec7 sinh h\u1ecdc bi\u1ebfn \u0111\u1ed9ng nh\u01b0 PRTA.<\/p>\n<h2>\ud83c\udf0d Prothena N\u0103m 2025: Nh\u00e0 \u0110\u1ed5i M\u1edbi Trong L\u0129nh V\u1ef1c Th\u1ea7n Kinh H\u1ecdc<\/h2>\n<p>Prothena Corporation \u0111ang c\u00e1ch m\u1ea1ng h\u00f3a \u0111i\u1ec1u tr\u1ecb b\u1ec7nh tho\u00e1i h\u00f3a th\u1ea7n kinh v\u1edbi chuy\u00ean m\u00f4n v\u1ec1 r\u1ed1i lo\u1ea1n protein. C\u00f4ng ty t\u1eadp trung v\u00e0o Alzheimer, Parkinson v\u00e0 c\u00e1c b\u1ec7nh amyloid hi\u1ebfm th\u00f4ng qua nghi\u00ean c\u1ee9u \u0111\u1ed9c quy\u1ec1n v\u00e0 h\u1ee3p t\u00e1c chi\u1ebfn l\u01b0\u1ee3c v\u1edbi c\u00e1c \u00f4ng l\u1edbn d\u01b0\u1ee3c ph\u1ea9m nh\u01b0 Bristol Myers Squibb v\u00e0 Novo Nordisk.<\/p>\n<p><strong>S\u1ef1 Th\u1eadt Th\u00fa V\u1ecb<\/strong>: N\u0103m 2025, nh\u00f3m nghi\u00ean c\u1ee9u c\u1ee7a Prothena ph\u00e1t hi\u1ec7n m\u1ed9t s\u1ed1 m\u1eabu g\u1ea5p protein sai l\u1ec7ch \u1edf b\u1ec7nh nh\u00e2n Alzheimer gi\u1ed1ng nh\u01b0 c\u1ea5u tr\u00fac origami \u2014 d\u1eabn \u0111\u1ebfn ph\u01b0\u01a1ng ph\u00e1p nghi\u00ean c\u1ee9u m\u1edbi g\u1ecdi l\u00e0 &#8220;protein origami&#8221; \u0111ang thu h\u00fat s\u1ef1 ch\u00fa \u00fd t\u1eeb c\u00e1c t\u1ed5 ch\u1ee9c nghi\u00ean c\u1ee9u l\u1edbn tr\u00ean to\u00e0n th\u1ebf gi\u1edbi.<\/p>\n<p>\u0110\u1ec3 c\u00f3 th\u00eam n\u1ed9i dung gi\u00e1o d\u1ee5c v\u00e0 ph\u00e2n t\u00edch th\u1ecb tr\u01b0\u1eddng, h\u00e3y truy c\u1eadp <a href=\"\/blog\">blog Pocket Option<\/a> c\u1ee7a ch\u00fang t\u00f4i, n\u01a1i ch\u00fang t\u00f4i ph\u00e2n t\u00edch c\u00e1c kh\u00e1i ni\u1ec7m \u0111\u1ea7u t\u01b0 ph\u1ee9c t\u1ea1p th\u00e0nh c\u00e1c chi\u1ebfn l\u01b0\u1ee3c c\u00f3 th\u1ec3 \u00e1p d\u1ee5ng.<\/p>\n"},"faq":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 b\u1eaft \u0111\u1ea7u mua c\u1ed5 phi\u1ebfu Prothena (PRTA)?","answer":"B\u1ea1n c\u1ea7n ch\u1ecdn m\u1ed9t n\u1ec1n t\u1ea3ng giao d\u1ecbch h\u1ed7 tr\u1ee3 NASDAQ v\u00e0 c\u1ed5 phi\u1ebfu l\u1ebb, x\u00e1c minh t\u00e0i kho\u1ea3n, n\u1ea1p ti\u1ec1n, t\u00ecm m\u00e3 PRTA, ch\u1ecdn lo\u1ea1i l\u1ec7nh ph\u00f9 h\u1ee3p v\u00e0 theo d\u00f5i v\u1ecb th\u1ebf c\u1ee7a m\u00ecnh."},{"question":"R\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o Prothena l\u00e0 g\u00ec?","answer":"C\u00e1c r\u1ee7i ro bao g\u1ed3m th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, ti\u00eau ti\u1ec1n m\u1eb7t l\u1edbn, r\u00e0o c\u1ea3n ph\u00e1p l\u00fd v\u00e0 pha lo\u00e3ng c\u1ed5 phi\u1ebfu do huy \u0111\u1ed9ng v\u1ed1n."},{"question":"Ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng c\u1ee7a c\u1ed5 phi\u1ebfu PRTA trong t\u01b0\u01a1ng lai ra sao?","answer":"D\u1ef1 b\u00e1o gi\u00e1 \u0111\u1ebfn n\u0103m 2030 c\u00f3 th\u1ec3 v\u01b0\u1ee3t 70 USD nh\u1edd c\u00e1c c\u1ed9t m\u1ed1c l\u00e2m s\u00e0ng, doanh thu h\u1ee3p t\u00e1c v\u00e0 m\u1edf r\u1ed9ng th\u1ecb tr\u01b0\u1eddng."},{"question":"T\u1ea1i sao n\u00ean s\u1eed d\u1ee5ng Pocket Option \u0111\u1ec3 \u0111\u1ea7u t\u01b0 v\u00e0o PRTA?","answer":"Pocket Option cho ph\u00e9p n\u1ea1p t\u1ed1i thi\u1ec3u 5 USD, x\u00e1c minh nhanh, h\u1ed7 tr\u1ee3 nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n v\u00e0 ph\u00f9 h\u1ee3p v\u1edbi nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi mu\u1ed1n b\u1eaft \u0111\u1ea7u nh\u1ecf."},{"question":"C\u00f3 nh\u1eefng t\u00edn hi\u1ec7u t\u00edch c\u1ef1c n\u00e0o cho Prothena trong n\u0103m 2025?","answer":"H\u1ee3p t\u00e1c v\u1edbi Novo Nordisk, k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m PRX012 kh\u1ea3 quan, l\u1ea1c quan c\u1ee7a nh\u00e0 ph\u00e2n t\u00edch v\u00e0 xu h\u01b0\u1edbng t\u0103ng tr\u01b0\u1edfng th\u1ecb tr\u01b0\u1eddng b\u1ec7nh tho\u00e1i h\u00f3a th\u1ea7n kinh."}],"faq_source":{"label":"FAQ","type":"repeater","formatted_value":[{"question":"L\u00e0m th\u1ebf n\u00e0o \u0111\u1ec3 b\u1eaft \u0111\u1ea7u mua c\u1ed5 phi\u1ebfu Prothena (PRTA)?","answer":"B\u1ea1n c\u1ea7n ch\u1ecdn m\u1ed9t n\u1ec1n t\u1ea3ng giao d\u1ecbch h\u1ed7 tr\u1ee3 NASDAQ v\u00e0 c\u1ed5 phi\u1ebfu l\u1ebb, x\u00e1c minh t\u00e0i kho\u1ea3n, n\u1ea1p ti\u1ec1n, t\u00ecm m\u00e3 PRTA, ch\u1ecdn lo\u1ea1i l\u1ec7nh ph\u00f9 h\u1ee3p v\u00e0 theo d\u00f5i v\u1ecb th\u1ebf c\u1ee7a m\u00ecnh."},{"question":"R\u1ee7i ro ch\u00ednh khi \u0111\u1ea7u t\u01b0 v\u00e0o Prothena l\u00e0 g\u00ec?","answer":"C\u00e1c r\u1ee7i ro bao g\u1ed3m th\u1ea5t b\u1ea1i trong th\u1eed nghi\u1ec7m l\u00e2m s\u00e0ng, ti\u00eau ti\u1ec1n m\u1eb7t l\u1edbn, r\u00e0o c\u1ea3n ph\u00e1p l\u00fd v\u00e0 pha lo\u00e3ng c\u1ed5 phi\u1ebfu do huy \u0111\u1ed9ng v\u1ed1n."},{"question":"Ti\u1ec1m n\u0103ng t\u0103ng tr\u01b0\u1edfng c\u1ee7a c\u1ed5 phi\u1ebfu PRTA trong t\u01b0\u01a1ng lai ra sao?","answer":"D\u1ef1 b\u00e1o gi\u00e1 \u0111\u1ebfn n\u0103m 2030 c\u00f3 th\u1ec3 v\u01b0\u1ee3t 70 USD nh\u1edd c\u00e1c c\u1ed9t m\u1ed1c l\u00e2m s\u00e0ng, doanh thu h\u1ee3p t\u00e1c v\u00e0 m\u1edf r\u1ed9ng th\u1ecb tr\u01b0\u1eddng."},{"question":"T\u1ea1i sao n\u00ean s\u1eed d\u1ee5ng Pocket Option \u0111\u1ec3 \u0111\u1ea7u t\u01b0 v\u00e0o PRTA?","answer":"Pocket Option cho ph\u00e9p n\u1ea1p t\u1ed1i thi\u1ec3u 5 USD, x\u00e1c minh nhanh, h\u1ed7 tr\u1ee3 nhi\u1ec1u ph\u01b0\u01a1ng th\u1ee9c r\u00fat ti\u1ec1n v\u00e0 ph\u00f9 h\u1ee3p v\u1edbi nh\u00e0 \u0111\u1ea7u t\u01b0 m\u1edbi mu\u1ed1n b\u1eaft \u0111\u1ea7u nh\u1ecf."},{"question":"C\u00f3 nh\u1eefng t\u00edn hi\u1ec7u t\u00edch c\u1ef1c n\u00e0o cho Prothena trong n\u0103m 2025?","answer":"H\u1ee3p t\u00e1c v\u1edbi Novo Nordisk, k\u1ebft qu\u1ea3 th\u1eed nghi\u1ec7m PRX012 kh\u1ea3 quan, l\u1ea1c quan c\u1ee7a nh\u00e0 ph\u00e2n t\u00edch v\u00e0 xu h\u01b0\u1edbng t\u0103ng tr\u01b0\u1edfng th\u1ecb tr\u01b0\u1eddng b\u1ec7nh tho\u00e1i h\u00f3a th\u1ea7n kinh."}]}},"yoast_head":"<!-- This site is optimized with the Yoast SEO Premium plugin v24.8 (Yoast SEO v27.2) - https:\/\/yoast.com\/product\/yoast-seo-premium-wordpress\/ -->\n<title>C\u00e1ch mua c\u1ed5 phi\u1ebfu Prothena Corporation plc (PRTA) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Prothena Corporation plc (PRTA)<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-prothena-corporation\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Prothena Corporation plc (PRTA) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Prothena Corporation plc (PRTA)\" \/>\n<meta property=\"og:description\" content=\"text\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-prothena-corporation\/\" \/>\n<meta property=\"og:site_name\" content=\"Pocket Option blog\" \/>\n<meta property=\"article:published_time\" content=\"2025-08-29T11:26:58+00:00\" \/>\n<meta name=\"author\" content=\"Signal\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Signal\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\/\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-prothena-corporation\/#article\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-prothena-corporation\/\"},\"author\":{\"name\":\"Signal\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"headline\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Prothena Corporation plc (PRTA) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Prothena Corporation plc (PRTA)\",\"datePublished\":\"2025-08-29T11:26:58+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-prothena-corporation\/\"},\"wordCount\":23,\"commentCount\":0,\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-prothena-corporation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"keywords\":[\"signal\"],\"articleSection\":[\"Signals\"],\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"CommentAction\",\"name\":\"Comment\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-prothena-corporation\/#respond\"]}]},{\"@type\":\"WebPage\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-prothena-corporation\/\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-prothena-corporation\/\",\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Prothena Corporation plc (PRTA) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Prothena Corporation plc (PRTA)\",\"isPartOf\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-prothena-corporation\/#primaryimage\"},\"image\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-prothena-corporation\/#primaryimage\"},\"thumbnailUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"datePublished\":\"2025-08-29T11:26:58+00:00\",\"author\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\"},\"breadcrumb\":{\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-prothena-corporation\/#breadcrumb\"},\"inLanguage\":\"vt-VT\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-prothena-corporation\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-prothena-corporation\/#primaryimage\",\"url\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"contentUrl\":\"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp\",\"width\":1408,\"height\":768},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-prothena-corporation\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\/\/pocketoption.com\/blog\/vt\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"C\u00e1ch mua c\u1ed5 phi\u1ebfu Prothena Corporation plc (PRTA) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Prothena Corporation plc (PRTA)\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#website\",\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/\",\"name\":\"Pocket Option blog\",\"description\":\"\",\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"vt-VT\"},{\"@type\":\"Person\",\"@id\":\"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe\",\"name\":\"Signal\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"vt-VT\",\"@id\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"url\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"contentUrl\":\"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g\",\"caption\":\"Signal\"},\"url\":\"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/\"}]}<\/script>\n<!-- \/ Yoast SEO Premium plugin. -->","yoast_head_json":{"title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Prothena Corporation plc (PRTA) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Prothena Corporation plc (PRTA)","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-prothena-corporation\/","og_locale":"en_US","og_type":"article","og_title":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Prothena Corporation plc (PRTA) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Prothena Corporation plc (PRTA)","og_description":"text","og_url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-prothena-corporation\/","og_site_name":"Pocket Option blog","article_published_time":"2025-08-29T11:26:58+00:00","author":"Signal","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Signal"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-prothena-corporation\/#article","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-prothena-corporation\/"},"author":{"name":"Signal","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"headline":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Prothena Corporation plc (PRTA) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Prothena Corporation plc (PRTA)","datePublished":"2025-08-29T11:26:58+00:00","mainEntityOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-prothena-corporation\/"},"wordCount":23,"commentCount":0,"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-prothena-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","keywords":["signal"],"articleSection":["Signals"],"inLanguage":"vt-VT","potentialAction":[{"@type":"CommentAction","name":"Comment","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-prothena-corporation\/#respond"]}]},{"@type":"WebPage","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-prothena-corporation\/","url":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-prothena-corporation\/","name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Prothena Corporation plc (PRTA) - \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Prothena Corporation plc (PRTA)","isPartOf":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-prothena-corporation\/#primaryimage"},"image":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-prothena-corporation\/#primaryimage"},"thumbnailUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","datePublished":"2025-08-29T11:26:58+00:00","author":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe"},"breadcrumb":{"@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-prothena-corporation\/#breadcrumb"},"inLanguage":"vt-VT","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-prothena-corporation\/"]}]},{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-prothena-corporation\/#primaryimage","url":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","contentUrl":"https:\/\/pocketoption.com\/blog\/wp-content\/uploads\/2025\/08\/banner_signals6.webp","width":1408,"height":768},{"@type":"BreadcrumbList","@id":"https:\/\/pocketoption.com\/blog\/vt\/news-events\/signal\/how-to-buy-prothena-corporation\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/pocketoption.com\/blog\/vt\/"},{"@type":"ListItem","position":2,"name":"C\u00e1ch mua c\u1ed5 phi\u1ebfu Prothena Corporation plc (PRTA) &#8211; \u0110\u1ea7u t\u01b0 v\u00e0o c\u1ed5 phi\u1ebfu Prothena Corporation plc (PRTA)"}]},{"@type":"WebSite","@id":"https:\/\/pocketoption.com\/blog\/vt\/#website","url":"https:\/\/pocketoption.com\/blog\/vt\/","name":"Pocket Option blog","description":"","potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pocketoption.com\/blog\/vt\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"vt-VT"},{"@type":"Person","@id":"https:\/\/pocketoption.com\/blog\/vt\/#\/schema\/person\/0011214e4ecd8db385a5d71d6f28bfbe","name":"Signal","image":{"@type":"ImageObject","inLanguage":"vt-VT","@id":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/e9506d2276dd67fbab5410249d21aea3e629528f720f69eb67c73bcf2a446ebd?s=96&d=mm&r=g","caption":"Signal"},"url":"https:\/\/pocketoption.com\/blog\/vt\/author\/signal\/"}]}},"po_author":null,"po__editor":null,"po_last_edited":null,"wpml_current_locale":"vt_VT","wpml_translations":{"pt_AA":{"locale":"pt_AA","id":358002,"slug":"how-to-buy-prothena-corporation","post_title":"Como comprar a\u00e7\u00f5es da Prothena Corporation plc (PRTA) - Investimento em a\u00e7\u00f5es da Prothena Corporation plc (PRTA)","href":"https:\/\/pocketoption.com\/blog\/pt\/news-events\/signal\/how-to-buy-prothena-corporation\/"}},"_links":{"self":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/358005","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/users\/129"}],"replies":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/comments?post=358005"}],"version-history":[{"count":0,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/posts\/358005\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media\/334036"}],"wp:attachment":[{"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/media?parent=358005"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/categories?post=358005"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pocketoption.com\/blog\/vt\/wp-json\/wp\/v2\/tags?post=358005"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}